Recent research highlights a significant concern for patients undergoing treatment for slow-growing brain tumors, specifically those classified as IDH mutated gliomas. While these tumors...
A recent study led by Erik Herzog, Ph.D., a distinguished professor of biology at Washington University in St. Louis, has uncovered significant findings regarding...
Findings from a biomarker analysis of the phase 3 AtTEnd trial (NCT03603184) indicate that high whole-exome sequencing (WES)–aneuploidy scores (W-AS) may serve as a...
UPDATE: A woman from Florida is grappling with a profound personal crisis as her ex-husband, who abandoned her during her battle with breast cancer,...
UPDATE: A cancer survivor is urgently seeking help as her daughter’s prolonged stay at home complicates her recovery. After moving in four years ago...